Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results

Provides Full-Year and First-Quarter 2024 Guidance REDWOOD CITY, Calif., Feb. 21, 2024 /PRNewswire/ –Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its fourth-quarter…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks